Structures by: Vallcorba O.
Total: 28
[Co(hfacac)4(BisPyBz)2]
C28H18CoF12N2O4
RSC Advances (2020) 10, 73 45090-45104
a=8.9127(4)Å b=9.8610(5)Å c=17.5409(9)Å
α=104.4(2)° β=96.3(2)° γ=97.5(2)°
[Co(hfacac)4(BisPyBz)2]
C14H9Co0.5F6NO2
RSC Advances (2020) 10, 73 45090-45104
a=8.77040(7)Å b=9.15990(6)Å c=10.04300(11)Å
α=62.9720(6)° β=71.4100(7)° γ=80.8890(6)°
[Zn(hfacac)4(BisPyBz)2]
C28H18F12N2O4Zn
RSC Advances (2020) 10, 73 45090-45104
a=8.900(2)Å b=9.8940(13)Å c=17.5110(17)Å
α=104.699(10)° β=96.02(2)° γ=97.45(3)°
[CoZn(hfacac)4(BisPyBz)2]
C28H18Co0.47F12N2O4Zn0.53
RSC Advances (2020) 10, 73 45090-45104
a=8.930(7)Å b=9.880(5)Å c=17.570(9)Å
α=104.57(6)° β=96.38(3)° γ=97.45(8)°
1,2,3-trimethylimidazolium tetrachlorideferrate(III)
C6H11N2,Cl4Fe
RSC Advances (2020) 10, 19 11200-11209
a=10.4559(1)Å b=9.2217(1)Å c=14.0803(2)Å
α=90.000° β=90.000° γ=90.000°
1,2,3-trimethylimidazolium tetrachlorideferrate(III)
C6H11N2,Cl4Fe
RSC Advances (2020) 10, 19 11200-11209
a=6.541(5)Å b=14.158(5)Å c=13.351(5)Å
α=90.000° β=95.590(5)° γ=90.000°
1,2,3-trimethylimidazolium tetrachlorideferrate(III)
C6H11N2,Cl4Fe
RSC Advances (2020) 10, 19 11200-11209
a=6.6159(2)Å b=14.2024(3)Å c=13.5728(3)Å
α=90.0000° β=95.905(2)° γ=90.0000°
C13H9Br2N5O,C3H6O
C13H9Br2N5O,C3H6O
Organic & biomolecular chemistry (2020) 18, 48 9810-9815
a=18.4913(6)Å b=4.76720(10)Å c=19.3160(7)Å
α=90° β=94.258(2)° γ=90°
C29H17N5Ni2O9
C29H17N5Ni2O9
CrystEngComm (2011) 13, 22 6831
a=13.6038(7)Å b=10.8508(7)Å c=19.3004(12)Å
α=90.0000° β=95.047(4)° γ=90.0000°
2(C29H18N5Ni2O10),6(O0.50),2(O0.50),2(O0.50)
2(C29H18N5Ni2O10),6(O0.50),2(O0.50),2(O0.50)
CrystEngComm (2011) 13, 22 6831
a=14.6280(16)Å b=11.6031(11)Å c=22.004(3)Å
α=90° β=116.141(9)° γ=90°
C7H12Cl2HgN2O
C7H12Cl2HgN2O
CrystEngComm (2011) 13, 21 6457
a=14.691(6)Å b=7.384(5)Å c=20.279(9)Å
α=90.00° β=90.00° γ=90.00°
C14H22Cd2Cl4N4O2
C14H22Cd2Cl4N4O2
CrystEngComm (2011) 13, 21 6457
a=8.457(5)Å b=8.555(4)Å c=9.024(5)Å
α=73.90(3)° β=81.76(4)° γ=65.32(2)°
C12 H22 N4 O2, C6 H6 O2
C12H22N4O2,C6H6O2
CrystEngComm (2018) 20, 2 237
a=25.43120(12)Å b=25.43120(12)Å c=6.06772(3)Å
α=90.00000° β=90.00000° γ=90.00000°
Bis([1,2,3]triazolo)[1,5-a:5',1'-k][1,10]phenanthroline
C12H22N4O2
CrystEngComm (2018) 20, 2 237
a=29.6240(17)Å b=6.0611(2)Å c=8.6488(3)Å
α=90.0000° β=101.974(4)° γ=90.0000°
C12H22N4O2
C12H22N4O2
CrystEngComm (2018) 20, 2 237
a=16.185(14)Å b=29.012(18)Å c=6.093(4)Å
α=90.00° β=90.00° γ=90.00°
N,N?-bis(2-(dimethylamino)ethyl)squaramide
C12H22N4O2
CrystEngComm (2018) 20, 2 237
a=6.0552(3)Å b=14.4565(8)Å c=15.8765(9)Å
α=90° β=97.773(2)° γ=90°
1-ethyl-2,3-dimethylimidazolium tetrachloroferrate
C7H13N2,Cl4Fe
RSC Adv. (2015)
a=9.6703(1)Å b=14.3513(2)Å c=9.5744(1)Å
α=90.0000° β=94.261(1)° γ=90.0000°
DimimFeCl4 (dimim=1,3-dimethylimidazolium)
C5H9N2,Cl4Fe
Phys. Chem. Chem. Phys. (2016)
a=6.5434(2)Å b=14.0286(2)Å c=6.5314(2)Å
α=90.0000° β=89.921(1)° γ=90.0000°
DimimFeCl4 (dimim=1,3-dimethylimidazolium)
C5H9N2,Cl4Fe
Phys. Chem. Chem. Phys. (2016)
a=14.1391(3)Å b=13.7039(3)Å c=13.2935(3)Å
α=90.0000° β=115.539(2)° γ=90.0000°
Copper(II) hexafluoroacetylacetonate bipyridine [Cu(hfacac)2(bpy)]
C20H10CuF12N2O4
Dalton transactions (Cambridge, England : 2003) (2015) 44, 16 7548-7553
a=7.8882(2)Å b=7.8882(2)Å c=38.0767(7)Å
α=90.0000° β=90.0000° γ=90.0000°
(<i>Z</i>)-3-Methyl-<i>N</i>-(7-nitroacridin-3-yl)-2,3-dihydro- 1,3-benzothiazol-2-imine
C21H14N4O2S
Acta Crystallographica Section C (2011) 67, 11 o425-o427
a=36.627(4)Å b=12.5071(10)Å c=7.5769(4)Å
α=90° β=90° γ=90°
1-ethyl-2,3-dimethylimidazolium chloride
C7H13N2,Cl
Crystal Growth & Design (2015) 15, 11 5207
a=7.99132(6)Å b=16.45676(13)Å c=6.68451(6)Å
α=90.0000° β=104.0416(5)° γ=90.0000°
1-ethyl-2,3-dimethylimidazolium bromide
C7H13N2,Br
Crystal Growth & Design (2015) 15, 11 5207
a=8.35615(5)Å b=17.03644(11)Å c=6.87656(5)Å
α=90.0000° β=104.2869(4)° γ=90.0000°
1-ethyl-2,3-dimethylimidazolium bromide
C7H13N2,Br
Crystal Growth & Design (2015) 15, 11 5207
a=7.84646(8)Å b=17.33453(17)Å c=6.75078(7)Å
α=90.0000° β=100.2869(6)° γ=90.0000°
1-ethyl-2,3-dimethylimidazolium chloride
C7H13N2,Cl
Crystal Growth & Design (2015) 15, 11 5207
a=8.36352(5)Å b=16.48723(11)Å c=6.71641(5)Å
α=90.0000° β=105.5362(4)° γ=90.0000°
DimimFeCl4 (dimim=1,3-dimethylimidazolium)
C5H9N2,Cl4Fe
Phys. Chem. Chem. Phys. (2016)
a=9.1242(1)Å b=13.8132(2)Å c=9.0359(1)Å
α=90.0000° β=90.0000° γ=90.0000°
1,3-dimethylimidazolium Tetrabromoferrate
C5H9N21,Br4Fe1
Inorganic chemistry (2014) 53, 16 8384-8396
a=6.745(3)Å b=14.364(3)Å c=6.759(3)Å
α=90.0000° β=90.80(2)° γ=90.0000°
1,3-dimethylimidazolium Tetrabromoferrate
C5H9N21,Br4Fe1
Inorganic chemistry (2014) 53, 16 8384-8396
a=6.7520(1)Å b=14.3717(3)Å c=6.7500(2)Å
α=90.0000° β=90.676(1)° γ=90.0000°